Neuronet releases its Knowledge Base dashboard

On 1 February, the members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme announced the launch of a pan-European Knowledge Base which brings together key information about the 18 projects of the Innovative Medicines Initiative (IMI) neurodegeneration (ND) portfolio, including the EPAD project. This comprehensive resource is an integral part of Neuronet’s endeavour to…

ALZFORUM

Alzforum conference blog mentions EPAD

A conference blog about the 13th Clinical Trials on Alzheimer’s Disease (CTAD) conference which took online, from 4-7 November 2020, has been published on the AlzForum website. The article mentions EPAD and can be read below: EPAD had been supported for five years by the Innovative Medicines Initiative (IMI), which is funded jointly by the…

ADDI launches new Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer’s disease and related dementias

The Alzheimer’s Disease Data Initiative (ADDI) has launched its Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. ADDI is a new global effort that aims to advance AD innovation by connecting researchers with the data needed to generate insights and inform the development of improved…

New paper investigating the prediction of Alzheimer’s disease biomarker status

The EPAD team has published a new paper entitled “Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study” in the journal Alzheimer’s Research Therapy. In this paper, authors from the University of Oxford and the Alzheimer Center Amsterdam tested the predictive utility of…

The Alzheimer’s Disease Data Initiative supports EPAD

The Alzheimer’s Disease Data Initiative (ADDI) aims to move Alzheimer’s disease (AD) innovation further and faster by connecting researchers with the data they need to generate insights to inform development of new, better treatments and diagnostic tools for AD and related dementias. We are pleased that ADDI is supporting the EPAD project. In 2016, EPAD…